Altimmune, Inc.ALTNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-3.28
↓ 89% vs avg
Percentile
P36
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
-1.74
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -3.28 | +34.7% |
| 2024 | -5.03 | +4.8% |
| 2023 | -5.28 | +32.6% |
| 2022 | -7.84 | -299.7% |
| 2021 | -1.96 | +57.3% |
| 2020 | -4.60 | -427.5% |
| 2019 | -0.87 | -242.3% |
| 2018 | 0.61 | +289.0% |
| 2017 | -0.32 | -102.9% |
| 2016 | 11.21 | - |